Have a personal or library account? Click to login
Nanostructured surface dental implants, a modern solution for the treatment of patients with chronic systemic diseases. Cover

Nanostructured surface dental implants, a modern solution for the treatment of patients with chronic systemic diseases.

Open Access
|Dec 2021

References

  1. 1. Hickin MP, Shariff JA, Jennette PJ, Finkelstein J, Papapanou PN. Incidence and Determinants of Dental Implant Failure: A Review of Electronic Health Records in a U.S. Dental School. J Dent Educ. 2017;81:1233–42.10.21815/JDE.017.08028966189
  2. 2. Derks J, Tomasi C. Peri-implant health and disease: a systematic review of current epidemiology. J Clin Periodontol. 2015;42:S158–71.10.1111/jcpe.1233425495683
  3. 3. Insua A, Monje A, Wang HL, Miron RJ. Basis of bone metabolism around dental implants during osseointegration and peri-implant bone loss. J Biomed Mater Res A. 2017;105(7):2075-2089.10.1002/jbm.a.3606028281321
  4. 4. World Health Organization. World report on ageing and health. Geneva, Switzerland: WHO Press; 2015.
  5. 5. Castellanos-Cosano L, Rodriguez-Perez A, Spinato S, et al. Descriptive retrospective study analyzing relevant factors related to dental implant failure. Med. Oral Patol. Oral Cir. Bucal. 2019;24:e726– e738.10.4317/medoral.23082690113931655831
  6. 6. Horikawa T, Odatsu T, Itoh T, et al. Retrospective cohort study of rough-surface titanium implants with at least 25 years’ function. Int. J. Implant Dent. 2017;3:42.10.1186/s40729-017-0101-7558511728875460
  7. 7. Jokstad A, Braegger U, Brunski JB, Carr AB, Naert I, Wennerberg A. Quality of dental implants. Int Dent J. 2003;53(6 Suppl 2):409-43.10.1111/j.1875-595X.2003.tb00918.x
  8. 8. Romanos G, Ciornei G, Jucan A, Malmstrom H, Gupta B. Clinical Implant Dentistry and Related Research. 2014;16(1):89-95.
  9. 9. Staedt H, Palarie V, Staedt A, et al. Primary Stability of Cylindrical and Conical Dental Implants in Relation to Insertion Torque-A Comparative Ex Vivo Evaluation. Implant Dent. 2017;26(2):250-255.10.1097/ID.000000000000053127922455
  10. 10. Chandar S, Kotian R, Madhyastha P, Kabekkodu SP, Rao P. In vitro evaluation of cytotoxicity and corrosion behavior of commercially pure titanium and Ti-6Al-4V alloy for dental implants. J Indian Prosthodont Soc. 2017;17(1):35-40.
  11. 11. Willis J, Li S, Crean SJ, Barrak FN. Is titanium alloy Ti-6Al-4 V cytotoxic to gingival fibroblasts-A systematic review. Clin Exp Dent Res. 2021;1-8.10.1002/cre2.444863828834018703
  12. 12. Budei D, Vaireanu D, Prepelita P, Popescu-Pelin G, Mincu M, Ciobotaru I. A comparative morphological study of titanium dioxide surface layer dental implants. Open Chemistry.2021;19(1):189-198.10.1515/chem-2021-0197
  13. 13. Lee JK, Choi DS, Jang I, Choi WY. Improved osseointegration of dental titanium implants by TiO2 nanotube arrays with recombinant human bone morphogenetic protein-2: a pilot in vivo study. Int J Nanomedicine.2015;10:1145-1154.
  14. 14. Yeo IL. Modifications of Dental Implant Surfaces at the Micro- and Nano-Level for Enhanced Osseointegration.Materials(Basel).2019;13(1):89.10.3390/ma13010089698201731878016
  15. 15. Zhang Y, Hu L, Lin M, Cao S, Feng Y, Sun S. RhBMP-2-Loaded PLGA/Titanium Nanotube Delivery System Synergistically Enhances Osseointegration. ACS Omega.2021;6(25):16364-16372.10.1021/acsomega.1c00851824647234235307
  16. 16. Yang J, Zhang H, Chan SM, et al. TiO2 Nanotubes Alleviate Diabetes-Induced Osteogenetic Inhibition. Int J Nanomedicine.2020;15:3523-3537.10.2147/IJN.S237008724444732547011
  17. 17. Pathak TK, Kroon RE, Craciun V, Popa M, Chifiriuc MC, Swart HC. Influence of Ag, Au and Pd noble metals doping on structural, optical and antimicrobial properties of zinc oxide and titanium dioxide nanomaterials. Heliyon.2019;5(3):e01333.10.1016/j.heliyon.2019.e01333642401630923765
  18. 18. Camargo SEA, Xia X, Fares C, et al. Nanostructured Surfaces to Promote Osteoblast Proliferation and Minimize Bacterial Adhesion on Titanium. Materials(Basel). 2021;14:4357.10.3390/ma14164357839830034442878
  19. 19. Aw MS, Addai-Mensah J, Losic D. A multi-drug delivery system with sequential release using titania nanotube arrays. Chem. Commun. 2012;48:3348–3350.
  20. 20. Kunrath MF, Penha N, Ng JC. Anodization as a promising surface treatment for drug delivery implants and a non-cytotoxic process for surface alteration: a pilot study. J Osseointegr. 2020;12(1):XXXX.
  21. 21. Politis C, Schoenaers J, Jacobs R, Agbaje JO. Wound Healing Problems in the Mouth. Front Physiol. 2016;7:507.10.3389/fphys.2016.00507508998627853435
  22. 22. Abreu AM, Douglas de Oliveira DW, Marinho SA, Lima NL, de Miranda JL, Verli FD. Effect of topical application of different substances on fibroplasia in cutaneous surgical wounds. ISRN Dermatol. 2012;2012:282973.10.5402/2012/282973332144022536526
  23. 23. Sambrook PN. Glucocorticoid-induced osteoporosis. International Journal of Rheumatic Diseases. 2008;11(4):381–385.10.1111/j.1756-185X.2008.00391.x
  24. 24. Cheng SL, Yang JW, Rifas L, Zhang SF, Avioli LV. Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology. 1994;134(1):277–286.10.1210/endo.134.1.82759458275945
  25. 25. Eijken M, Koedam M, van Driel M, Buurman CJ, Pols HAP, van Leeuwen JPTM. The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization. Molecular and Cellular Endocrinology. 2006;248(1-2):87–93.10.1016/j.mce.2005.11.03416406260
  26. 26. Igarashi M, Kamiya N, Hasegawa M, Kasuya T, Takahashi T, Takagi M. Inductive effects of dexamethasone on the gene expression of Cbfa1, Osterix and bone matrix proteins during differentiation of cultured primary rat osteoblasts. Journal of Molecular Histology. 2004;35(1):3–10.10.1023/B:HIJO.0000020883.33256.fe
  27. 27. Wang H, Pang B, Li Y, Zhu D, Pang T, Liu Y. Dexamethasone has variable effects on mesenchymal stromal cells. Cytotherapy. 2012;14(4):423–430.10.3109/14653249.2011.65273522364108
  28. 28. Zhao M, Li P, Xu H, et al. Dexamethasone-Activated MSCs Release MVs for Stimulating Osteogenic Response. Stem Cells Int. 2018;2018:7231739.10.1155/2018/7231739592652429760734
  29. 29. Yang Y, Hu H, Zeng M, et al. The survival rates and risk factors of implants in the early stage: a retrospective study. BMC Oral Health. 2021;21(1):293.10.1186/s12903-021-01651-8818869734107931
  30. 30. Do TA, Le HS, Shen YW, Huang HL, Fuh LJ. Risk Factors related to Late Failure of Dental Implant-A Systematic Review of Recent Studies. Int J Environ Res Public Health. 2020;17(11):3931.10.3390/ijerph17113931731280032498256
Language: English
Page range: 37 - 43
Submitted on: Oct 23, 2021
|
Accepted on: Nov 15, 2021
|
Published on: Dec 30, 2021
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2021 Mircea Suciu, Dragoş Vladimir Budei, Florentin Daniel Berneanu, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.